현대바이오: management transactions · South Korea · DART (FSS)

Browse the full directors' dealings record of 현대바이오, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 현대바이오 has recorded 1 public disclosures. Market capitalisation: €1,054.5bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 현대바이오. All data is openly available.